We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Momenta Asks 1st Circ. To Affirm Enoxaparin Suit Immunity

Law360, Fort Wayne (December 6, 2016, 2:17 PM EST) -- Momenta Pharmaceuticals Inc. asked the First Circuit Monday to uphold a determination that the company is immune from an antitrust action by Amphastar Pharmaceuticals Inc. over anticoagulant enoxaparin, saying a federal judge correctly held the Noerr-Pennington doctrine bars the claims.

The doctrine provides that there can be no antitrust liability for injuries caused directly by a private party’s petition to the government. Such a petition was made when Momenta and Sandoz Inc. obtained a court-ordered injunction in a patent infringement suit preventing Amphastar from selling enoxaparin...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.